NCT01635114

Effect of resVida on Liver Fat Content

Evaluate the Effects of resVidaTM on Liver Fat Content, Body Fat Distribution and Insulin Sensitivity

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 112 (actual)
• Sponsor: University Hospital Tuebingen · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to investigate the effects of the antioxidant "resveratrol" on liver fat content, body-composition and insulin sensitivity Resveratrol is found in grape skin, wine, peanuts, and mulberries and is thought to have health benefits such as improving fat metabolism, insulin action, and possibly extending lifespan. resVida™ is the name for the dietary supplement containing the natural antioxidant "resveratrol". resVida™ will be supplied by DSM Nutritional Products, Ltd. resVida™ is considered a dietary supplement, and therefore it is not an approved drug by German Authority. It is regulated like a food. The makers of resVida™ make no claim that this supplement is meant to treat any ailment. This study is designed to investigate the health benefits of resveratrol.

Conditions

• Elevated Liver Fat Content and Insulin Resistance

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	resveratrol	150 mg resVida per day for 12 weeks
DIETARY_SUPPLEMENT	Placebo	Placebo for 12 weeks

Timeline

• Start date: 2012-06-01
• Primary completion: 2013-12-01
• Completion: 2015-09-01
• First posted: 2012-07-06
• Last updated: 2016-10-25

Locations

1 site across 1 country: Germany